Cargando…
Understanding the need for digital twins’ data in patient advocacy and forecasting oncology
Digital twins are made of a real-world component where data is measured and a virtual component where those measurements are used to parameterize computational models. There is growing interest in applying digital twins-based approaches to optimize personalized treatment plans and improve health out...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667907/ https://www.ncbi.nlm.nih.gov/pubmed/38028666 http://dx.doi.org/10.3389/frai.2023.1260361 |
_version_ | 1785139354015891456 |
---|---|
author | Chang, Hung-Ching Gitau, Antony M. Kothapalli, Siri Welch, Danny R. Sardiu, Mihaela E. McCoy, Matthew D. |
author_facet | Chang, Hung-Ching Gitau, Antony M. Kothapalli, Siri Welch, Danny R. Sardiu, Mihaela E. McCoy, Matthew D. |
author_sort | Chang, Hung-Ching |
collection | PubMed |
description | Digital twins are made of a real-world component where data is measured and a virtual component where those measurements are used to parameterize computational models. There is growing interest in applying digital twins-based approaches to optimize personalized treatment plans and improve health outcomes. The integration of artificial intelligence is critical in this process, as it enables the development of sophisticated disease models that can accurately predict patient response to therapeutic interventions. There is a unique and equally important application of AI to the real-world component of a digital twin when it is applied to medical interventions. The patient can only be treated once, and therefore, we must turn to the experience and outcomes of previously treated patients for validation and optimization of the computational predictions. The physical component of a digital twins instead must utilize a compilation of available data from previously treated cancer patients whose characteristics (genetics, tumor type, lifestyle, etc.) closely parallel those of a newly diagnosed cancer patient for the purpose of predicting outcomes, stratifying treatment options, predicting responses to treatment and/or adverse events. These tasks include the development of robust data collection methods, ensuring data availability, creating precise and dependable models, and establishing ethical guidelines for the use and sharing of data. To successfully implement digital twin technology in clinical care, it is crucial to gather data that accurately reflects the variety of diseases and the diversity of the population. |
format | Online Article Text |
id | pubmed-10667907 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-106679072023-11-10 Understanding the need for digital twins’ data in patient advocacy and forecasting oncology Chang, Hung-Ching Gitau, Antony M. Kothapalli, Siri Welch, Danny R. Sardiu, Mihaela E. McCoy, Matthew D. Front Artif Intell Artificial Intelligence Digital twins are made of a real-world component where data is measured and a virtual component where those measurements are used to parameterize computational models. There is growing interest in applying digital twins-based approaches to optimize personalized treatment plans and improve health outcomes. The integration of artificial intelligence is critical in this process, as it enables the development of sophisticated disease models that can accurately predict patient response to therapeutic interventions. There is a unique and equally important application of AI to the real-world component of a digital twin when it is applied to medical interventions. The patient can only be treated once, and therefore, we must turn to the experience and outcomes of previously treated patients for validation and optimization of the computational predictions. The physical component of a digital twins instead must utilize a compilation of available data from previously treated cancer patients whose characteristics (genetics, tumor type, lifestyle, etc.) closely parallel those of a newly diagnosed cancer patient for the purpose of predicting outcomes, stratifying treatment options, predicting responses to treatment and/or adverse events. These tasks include the development of robust data collection methods, ensuring data availability, creating precise and dependable models, and establishing ethical guidelines for the use and sharing of data. To successfully implement digital twin technology in clinical care, it is crucial to gather data that accurately reflects the variety of diseases and the diversity of the population. Frontiers Media S.A. 2023-11-10 /pmc/articles/PMC10667907/ /pubmed/38028666 http://dx.doi.org/10.3389/frai.2023.1260361 Text en Copyright © 2023 Chang, Gitau, Kothapalli, Welch, Sardiu and McCoy. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Artificial Intelligence Chang, Hung-Ching Gitau, Antony M. Kothapalli, Siri Welch, Danny R. Sardiu, Mihaela E. McCoy, Matthew D. Understanding the need for digital twins’ data in patient advocacy and forecasting oncology |
title | Understanding the need for digital twins’ data in patient advocacy and forecasting oncology |
title_full | Understanding the need for digital twins’ data in patient advocacy and forecasting oncology |
title_fullStr | Understanding the need for digital twins’ data in patient advocacy and forecasting oncology |
title_full_unstemmed | Understanding the need for digital twins’ data in patient advocacy and forecasting oncology |
title_short | Understanding the need for digital twins’ data in patient advocacy and forecasting oncology |
title_sort | understanding the need for digital twins’ data in patient advocacy and forecasting oncology |
topic | Artificial Intelligence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667907/ https://www.ncbi.nlm.nih.gov/pubmed/38028666 http://dx.doi.org/10.3389/frai.2023.1260361 |
work_keys_str_mv | AT changhungching understandingtheneedfordigitaltwinsdatainpatientadvocacyandforecastingoncology AT gitauantonym understandingtheneedfordigitaltwinsdatainpatientadvocacyandforecastingoncology AT kothapallisiri understandingtheneedfordigitaltwinsdatainpatientadvocacyandforecastingoncology AT welchdannyr understandingtheneedfordigitaltwinsdatainpatientadvocacyandforecastingoncology AT sardiumihaelae understandingtheneedfordigitaltwinsdatainpatientadvocacyandforecastingoncology AT mccoymatthewd understandingtheneedfordigitaltwinsdatainpatientadvocacyandforecastingoncology |